\
&
Contact us
This was 2 years ago
LocationBrussels
There is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The Horizon Europe EU-CIP project is organising its annual conference on critical infrastructure resilience, co-organised with the ECSCI cluster.
The various sessions include speakers from various organisations, including the European Commission (DG Home and JRC), large enterprises, various universities and logistic hubs.
The conference will be followed by the final conference of the Praetorian project on 22 September, in the same venue. You can register for the Praetorian conference through the same registration form as for the EU-CIP conference.
More information, including registration information, can be found on the main announcement.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.